Skip to Content
Biotechnology and health

A New Gene “Silencing” Drug Could Help Slow Huntington’s Disease

December 11, 2017

A human trial shows that synthetic strands of DNA meant to "silence" a problematic gene can slow down the production of a protein that leads to irreversible damage in the brain.

Huntington’s disease is caused by a mutation in the HTT gene that causes the body to create a rogue version of a protein called huntingtin; this altered protein damages parts of the brain. The new drug, called Ionis-HTTRx, is a small piece of synthetic DNA that blocks the production of that protein by silencing the HTT gene. The drug has to be injected into the fluid around the spine using a large needle.

Now the company behind the drug, Ionis Pharmaceuticals, reports that a phase 1 trial of 46 patients has shown that the drug successfully lowers the level of the toxic protein in the nervous system. And the results have caught the eye of Big Pharma: Roche has announced that it’s licensing the drug from Ionis for $45 million and will take on its development going forward.

Sarah Tabrizi, a professor of clinical neurology at University College London who ran the clinical trial, said in a statement that the results are of “ground-breaking importance for Huntington’s disease patients and families.” Now Roche will carry out further trials to investigate whether the reduced protein levels have a meaningful impact on the progression of the disease itself.

This isn’t the first time that so-called gene silencing drugs have been shown to be successful (see “How a Boy’s Lazarus-like Revival Points to a New Generation of Drugs” and “Gene-Silencing Drugs Finally Show Promise”). But it is the first drug to target the underlying cause of Huntington’s.

According to the Guardian, some researchers hope that the same technique could be modified and applied to other incurable brain diseases, like Alzheimer’s and Parkinson’s.

Deep Dive

Biotechnology and health

The Biggest Questions: What is death?

New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.

Some deaf children in China can hear after gene therapy treatment

After deafness treatment, Yiyi can hear her mother and dance to the music. But why is it so noisy at night?

Scientists just drafted an incredibly detailed map of the human brain

A massive suite of papers offers a high-res view of the human and non-human primate brain.

Three people were gene-edited in an effort to cure their HIV. The result is unknown.

CRISPR is being used in an experimental effort to eliminate the virus that causes AIDS.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.